Company
Headquarters: Vancouver, BC, Canada
CEO: Mr. Nicholas Peter Karos
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $158.96 B |
| Vertex Pharmaceuticals Incorporated | $115.92 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $82.28 B |
| Marinomed Biotech AG | $70.11 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Universal Ibogaine Inc. provides treatment for addiction patients in Canada. It provides ibogaine addiction treatment to patients suffering from opioid addiction; and operates clinics that offer non-medical detox, inpatient and outpatient treatment, and aftercare recovery programs, as well as addiction intervention services. The company was incorporated in 2018 and is based in Vancouver, Canada.
Universal Ibogaine, Inc. has the following listings and related stock indices.
Stock: TSXV: IBO